Ori Biotech
Ori Biotech develops the IRO platform, an automated cell and gene therapy (CGT) manufacturing system designed to scale production from R&D to GMP standards. The technology utilizes a novel bioreactor and automated sterile connection tools to improve biological performance and throughput while reducing manufacturing costs. The company serves therapy developers and clinical institutions seeking to transition from manual processes to digital, closed-system automation.
Visit websiteLondon, UK
Healthtech
Biotechnology
Life Sciences
Manufacturing Technology
Funding summary
- Total raised
- €121.4M
- Funding rounds
- 3
Investors in Ori Biotech
Investors on record for Ori Biotech. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Ori Biotech?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors